Research Overview
The minimal bioregulator
Vilon matters historically because it demonstrated that a two-residue peptide could be carried forward from a crude tissue extract as a defined synthetic entity. Everything later in the series — the tripeptides and tetrapeptides — follows that template of stripping an extract down to a short, reproducible sequence.
Chromatin and lymphocyte studies
Several published experiments have applied KE to cultured human lymphocytes, including cells from older donors, and reported changes in heterochromatin decondensation assessed by cytological staining. The interpretation offered by those authors is that the peptide reaches the nucleus and alters how tightly chromatin is packed, thereby changing the accessibility of certain genes. Independent replication outside the originating groups remains limited.
Immune and thymic models
Long-term rodent experiments
Vilon features in a series of long-duration rodent studies from the same research programme in which survival, spontaneous tumour incidence, and biochemical markers were followed across the animals' lifespans. These studies are frequently cited in discussions of geroprotective peptides, and they are also frequently criticised for small group sizes and limited blinding, which is worth weighing before designing follow-up work.
Practical considerations
KE is small and strongly polar, which makes it easy to dissolve but also means researchers should confirm concentration analytically rather than assuming complete transfer from the vial. Because the molecule carries both a free amine and a free carboxylate, buffer pH can influence its behaviour in binding assays.
